These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8969921)
21. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p. Schmitz HP; Jöckel J; Block C; Heinisch JJ J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853 [TBL] [Abstract][Full Text] [Related]
22. C2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound state. Kohout SC; Corbalán-García S; Torrecillas A; Goméz-Fernandéz JC; Falke JJ Biochemistry; 2002 Sep; 41(38):11411-24. PubMed ID: 12234184 [TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. Huang WC; Chen JJ; Inoue H; Chen CC J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358 [TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. Wang HQ; Kim MP; Tiano HF; Langenbach R; Smart RC Mol Pharmacol; 2001 Apr; 59(4):860-6. PubMed ID: 11259631 [TBL] [Abstract][Full Text] [Related]
25. Direct association and translocation of PKC-alpha with calponin. Patil SB; Pawar MD; Bitar KN Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G954-63. PubMed ID: 14726309 [TBL] [Abstract][Full Text] [Related]
26. Differential inhibition by alpha and epsilonPKC pseudosubstrate sequences: a putative mechanism for preferential PKC activation in neonatal cardiac myocytes. Johnson JA Life Sci; 2004 May; 74(25):3153-72. PubMed ID: 15081580 [TBL] [Abstract][Full Text] [Related]
27. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain. Sullivan JP; Connor JR; Shearer BG; Burch RM Mol Pharmacol; 1992 Jan; 41(1):38-44. PubMed ID: 1732721 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of atrial natriuretic peptide receptor/guanylyl cyclase- A signaling pathway antagonizes the activation of protein kinase C-alpha in murine Leydig cells. Kumar R; von Geldern TW; Calle RA; Pandey KN Biochim Biophys Acta; 1997 Apr; 1356(2):221-8. PubMed ID: 9150279 [TBL] [Abstract][Full Text] [Related]
29. 14-3-3 inhibits the Dictyostelium myosin II heavy-chain-specific protein kinase C activity by a direct interaction: identification of the 14-3-3 binding domain. Matto-Yelin M; Aitken A; Ravid S Mol Biol Cell; 1997 Oct; 8(10):1889-99. PubMed ID: 9348531 [TBL] [Abstract][Full Text] [Related]
30. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. Gill PK; Gescher A; Gant TW Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907 [TBL] [Abstract][Full Text] [Related]
31. Chemoattractant-mediated increases in cGMP induce changes in Dictyostelium myosin II heavy chain-specific protein kinase C activities. Dembinsky A; Rubin H; Ravid S J Cell Biol; 1996 Aug; 134(4):911-21. PubMed ID: 8769416 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. Tamir A; Granot Y; Isakov N J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733 [TBL] [Abstract][Full Text] [Related]
33. Reconstitution of protein kinase C alpha function by the protein kinase C beta-I carboxy terminus. Parissenti AM; Su L; Riedel H Mol Cell Endocrinol; 1993 Dec; 98(1):9-16. PubMed ID: 8143918 [TBL] [Abstract][Full Text] [Related]
34. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518 [TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of cyclic AMP-dependent protein kinase, myosin light chain kinase and protein kinase C by azaacridine and acridine derivatives. Chen Q; Deady LW; Polya GM Biol Chem Hoppe Seyler; 1994 Apr; 375(4):223-35. PubMed ID: 8060530 [TBL] [Abstract][Full Text] [Related]
36. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Kumar R; Cartledge WA; Lincoln TM; Pandey KN Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136 [TBL] [Abstract][Full Text] [Related]
37. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-zeta. van Dijk M; Muriana FJ; van Der Hoeven PC; de Widt J; Schaap D; Moolenaar WH; van Blitterswijk WJ Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):693-9. PubMed ID: 9169602 [TBL] [Abstract][Full Text] [Related]
38. Deletion analysis of protein kinase C inactivation by calphostin C. Rotenberg SA; Huang MH; Zhu J; Su L; Riedel H Mol Carcinog; 1995 Jan; 12(1):42-9. PubMed ID: 7529505 [TBL] [Abstract][Full Text] [Related]
39. A factor with a zinc- and phorbol ester-binding domain is necessary for endosome fusion. Aballay A; Arenas NG; Quest AF; Mayorga LS Exp Cell Res; 1997 Aug; 235(1):28-34. PubMed ID: 9281349 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin. Bishop WR; Petrin J; Wang L; Ramesh U; Doll RJ Biochem Pharmacol; 1990 Nov; 40(9):2129-35. PubMed ID: 2242040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]